Michael Halberstam

Chairman Emeritus at ISA Group, a Material Company

📍 United States🔄 Updated September 2026💼 3 investments📅 12 years investing🗓 Last invested Jul 2022
Angel investor🌍 United States
3
Total investments
1
Early stage
1
Mid stage
0
Late stage
12y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Senior Advisor
Jan 2022
Indico Labs helps Market Research agencies to tell stories in less time. We help researchers to make reports faster, automating the way you add data to end reports. Make charts that are simple, and accurate, in 80% less time than doing it manually. Software Solutions: Indico Labs SlideGen is a self-service, data-visualization and report automation application which enables researchers to create PowerPoint reports directly from Excel tables. For more information contact: info@indicolabs.io
Seed Investor
Sep 2014
AppliedVR is unleashing the power of Immersive Therapeutics (ITx), a new category of medical devices that harness the unique properties of virtual reality (VR) to treat some of the most debilitating chronic conditions. AppliedVR’s easy-to-use and engaging non-pharmacological platform enables patients to access our validated therapies from the comfort of home. The Company’s flagship product, RelieVRx®, is the first VR-based FDA-authorized medical device to treat chronic lower back pain (CLBP), a condition that affects 72 million adults in the US alone. RelieVRx has achieved multiple industry firsts including a unique CMS code and coverage category, paving the pathway to broad accessibility. Learn more about AppliedVR, headquartered in Los Angeles, at appliedvr.io. AppliedVR’s RelieVRx® program optimizes the proven benefits of cognitive behavioral therapy (CBT) through a sequential, immersive therapeutic program which activates the brain’s innate healing power. Rigorously validated to reduce pain and pain intensity in multiple clinical trials totaling over 1,200 patients, RelieVRx is the first prescription virtual reality medical device to receive Breakthrough Device Designation and De Novo authorization by the FDA for the treatment of chronic lower back pain. For more information, visit relievrx.com.
Experience · 3 entries
All (3)
Investments (3)
2022
Seed Investor
Jul 2022
Our multi-patented system, TAG (Technical Authentication & Grading), is an accurate, consistent, and reproducible card grading technology. TAG has been awarded 4 patents covering 134 claims and counting. (#9767163, #10146841, #10445330, #10459931) TAG is the industry’s never-before available solution to the numerous inconsistencies that result from subjective grading practices existing in the market today. It is our mission to use innovation, to apply technologies, and to create for each collector: transparency, accuracy, and consistency for every card grade.
Investor & Senior Advisor
Jan 2022
Indico Labs helps Market Research agencies to tell stories in less time. We help researchers to make reports faster, automating the way you add data to end reports. Make charts that are simple, and accurate, in 80% less time than doing it manually. Software Solutions: Indico Labs SlideGen is a self-service, data-visualization and report automation application which enables researchers to create PowerPoint reports directly from Excel tables. For more information contact: info@indicolabs.io
2014
Seed Investor
Sep 2014
AppliedVR is unleashing the power of Immersive Therapeutics (ITx), a new category of medical devices that harness the unique properties of virtual reality (VR) to treat some of the most debilitating chronic conditions. AppliedVR’s easy-to-use and engaging non-pharmacological platform enables patients to access our validated therapies from the comfort of home. The Company’s flagship product, RelieVRx®, is the first VR-based FDA-authorized medical device to treat chronic lower back pain (CLBP), a condition that affects 72 million adults in the US alone. RelieVRx has achieved multiple industry firsts including a unique CMS code and coverage category, paving the pathway to broad accessibility. Learn more about AppliedVR, headquartered in Los Angeles, at appliedvr.io. AppliedVR’s RelieVRx® program optimizes the proven benefits of cognitive behavioral therapy (CBT) through a sequential, immersive therapeutic program which activates the brain’s innate healing power. Rigorously validated to reduce pain and pain intensity in multiple clinical trials totaling over 1,200 patients, RelieVRx is the first prescription virtual reality medical device to receive Breakthrough Device Designation and De Novo authorization by the FDA for the treatment of chronic lower back pain. For more information, visit relievrx.com.
Investment activity
2014–2022 · 3 investments
2014120222
Recent (last 2 years)Earlier